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Hypertensive crisis presents as an acute elevation of blood 
pressure (BP) mostly associated with systemic symptoms 
as a consequence of elevated BP.1 It is a common problem 
in hypertensive patients and may cause life-threatening 
complications.2–4 Therefore, the search for risk factors associ-
ated with hypertensive crises is important. Current knowledge 
about such risk factors originates from retrospective cross-
 sectional or survey studies.3–8 In these studies, ineffective BP 
control as well as nonadherence with antihypertensive treat-
ment were identified as independent risk factors for hyperten-
sive crises. However, selection or recall bias and confounding 
may be inherent in retrospective studies and the findings of 
these studies have never been confirmed in prospective  studies. 
One recent systematic review concluded that although poor 
compliance is assumed to be an important explanation for 
inadequate BP control, any convincing empirical evidence to 
support this hypothesis is currently lacking.9 Regarding pre-
dictors of hypertensive crisis, only one prospective study was 
conducted so far.10 Predictors in this study, however, were 
confined to BP measures derived from 24-h ambulatory BP 
monitoring (ABPM). We therefore conducted a prospective 
longitudinal study elucidating a broad spectrum of potential 
risk factors promoting hypertensive crises.
Methods
Study population. For participation in this prospective longi-
tudinal study, 112 consecutive patients aged 18 years or older 
in whom 24-h ABPM was performed during a predefined 
time-period (December 2006–August 2008) at the medical 
outpatient unit of the University Hospital of Bern were eligible. 
Patients were referred to 24-h ABPM by their treating physi-
cian at the medical outpatient unit or by a local general prac-
titioner for the evaluation of either suspected hypertension or 
for the evaluation of BP during therapy. Patients with at least 
one of the two following a priori criteria were excluded. First, 
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Background
Current knowledge about risk factors promoting hypertensive crisis 
originates from retrospective data. Therefore, potential risk factors of 
hypertensive crisis were assessed in a prospective longitudinal study.
Methods
Eighty-nine patients of the medical outpatient unit at the University 
Hospital of Bern (Bern, Switzerland) with previously diagnosed 
hypertension participated in this study. At baseline, 33 potential risk 
factors were assessed. All patients were followed-up for the outcome 
of hypertensive crisis. Cox regression models were used to detect 
relationships between risk factors and hypertensive crisis (defined as 
acute rise of systolic blood pressure (BP) ≥200 mm Hg and/or diastolic 
BP ≥120 mm Hg).
results
The mean duration of follow-up was 1.6 ± 0.3 years (range 1.0–2.4 
years). Four patients (4.5%) were lost to follow-up. Thirteen 
patients (15.3%) experienced hypertensive crisis during follow-up. 
Several potential risk factors were significantly associated with 
hypertensive crisis: female sex, higher grades of obesity, the 
presence of a hypertensive or coronary heart disease, the presence 
of a somatoform disorder, a higher number of antihypertensive 
drugs, and nonadherence to medication. As measured by the hazard 
ratio, nonadherence was the most important factor associated 
with hypertensive crisis (hazard ratio 5.88, 95% confidence interval 
1.59–21.77, P < 0.01).
conclusions
This study identified several potential risk factors of hypertensive 
crisis. Results of this study are consistent with the hypothesis that 
improvement of medical adherence in antihypertensive therapy 
would help to prevent hypertensive crises. However, larger studies 
are needed to assess potential confounding, other risk factors and 
the possibility of interaction between predictors.
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21 patients who did not have high BP according to current 
guidelines were excluded.1 The rationale for this approach was 
based on the assumption that the incidence of hypertensive 
crisis in these normotensive patients is very low and that risk 
factors differ considerably between patients with or without 
hypertension (e.g., pre-eclampsia or drug intoxication as risk 
factors in normotensive patients). Second, 2 patients who did 
not give consent to study participation were excluded. Finally, 
89 patients constituted the study population (Figure 1). The 
institutional ethical committee approved the study, which was 
conducted in compliance with the Declaration of Helsinki.
The date of the 24-h ABPM (Boso TM-2430; Boso, 
Jungingen, Germany or SunTech Oscar 2; SunTech Medical, 
Morrisville, NC) was utilized to set the start point for each 
subject. At study start, hypertension was diagnosed in all par-
ticipants according to current guidelines.1 Clinical history was 
assessed in all patients. Urine test, creatinine, potassium, fast-
ing plasma glucose, and thyroid-stimulating hormone were 
consistently measured in all patients as part of standard of care. 
Further diagnostic tests for secondary causes (e.g., diagnostic 
imaging of renal artery and kidneys, cortisol, renin, aldos-
terone) were performed, if clinical findings suggested such a 
disorder. An electrocardiogram was performed at the discre-
tion of the treating physician. Antihypertensive treatment was 
initiated by the treating physician according to current guide-
lines. Drug therapy was begun, if BP goals were not achieved 
by lifestyle modification, or intensified, if the patient already 
had drug therapy and BP was inadequately controlled.
Assessment of risk factors. The following potential risk factors 
for hypertensive crisis were assessed: age, sex, baseline systolic 
or diastolic BP, stage of hypertension at the time of diagno-
sis, duration of known hypertension, presence of hypertensive 
heart disease or renal disease, body mass index (BMI), grade 
of obesity, presence of cardiovascular risk factors other than 
hypertension (diabetes mellitus, smoking, or hyperlipidemia), 
presence of coronary or peripheral artery disease, presence of 
cerebrovascular disease, alcohol abuse, depression, somato-
form disorder, hyperthyroidism, thyroid-stimulating hormone, 
creatinine, proteinuria, the number of antihypertensive drugs, 
nonadherence to medication, and characteristics of the 24-h 
ABPM (systolic, mean, or diastolic BP values during day- or 
night-time, presence of nocturnal dipping, and inadequate BP 
control). Definitions used for these risk factors are provided 
hereafter.
The stage of hypertension was defined according to cur-
rent guidelines.1 Stage 1 hypertension constituted systolic 
BP of 140–159 mm Hg or diastolic BP of 90–99 mm Hg, stage 
2 hypertension systolic BP of ≥160 mm Hg or diastolic BP of 
≥100 mm Hg. Hypertensive heart disease was considered 
present, if electrocardiogram (performed in 60 patients) or 
echocardiography (performed in 31 patients) were compatible 
with hypertensive heart disease. Grade of obesity was defined 
based on the BMI (BMI <30.0 grade 0, BMI 30.0–34.9 grade 
1, BMI 35.0–39.9 grade 2, BMI ≥40.0 grade 3).11,12 Diagnosis 
of diabetes mellitus was made, if fasting plasma glucose was 
≥7 mmol/l on at least two different days or if postprandial 
plasma glucose was ≥11.1 mmol/l.13 Coronary artery disease 
was considered present, if the diagnosis was made earlier based 
on appropriate diagnostic testing (e.g., coronary angio graphy) 
or based on a known previous coronary event. Presence 
of peripheral artery disease or cardiovascular disease was 
defined accordingly. Alcohol abuse was considered present, 
if the daily alcohol consumption exceeded three drinks a day 
( corresponding to ~30 g/day).14 Depression or somatoform 
disorders were considered present, if these diagnoses had 
been previously made by experienced physicians according to 
DSM-IV criteria. The number of antihypertensive drugs was 
assessed baseline. A patient was considered nonadherent to 
medication, if the treating physician asked the patient whether 
he took medication irregularly and if irregular mediation use 
was documented in the medical record. Nocturnal BP dipping 
was defined as >10% dipping of average mean arterial pres-
sure at night compared to daytime.15 Inadequate BP control 
was defined as average systolic BP >140 mm Hg and/or average 
diastolic BP >90 mm Hg during 24-h ABPM.
Outcome and follow-up. Hypertensive crisis constituted the 
main outcome. The following criteria had to be fulfilled for 
the diagnosis of a hypertensive crisis according to  current 
literature: (i) systolic BP ≥200 mm Hg and/or diastolic BP 
≥120 mm Hg and (ii) rise in BP was acute.1,16,17 Thus, the 
end-point definition included hypertensive urgencies (mildly/
asymptomatic acute elevation of BP) as well as hypertensive 
emergencies (acute elevation of BP with end-organ damage). 
For the systolic and diastolic BP values, self-reported infor-
mation on at least two repeated BP measurements at home or 
record-based information of at least two BP measurements in 
an office or a hospital setting was required.
End points were assessed ~1–2 years after the 24-h ABPM. 
Information was obtained from several sources by two spe-
cially trained physicians. First, outpatient medical records were 
reviewed in all patients for a diagnosis or reporting of a hyper-
tensive crisis because most patients had routine follow-up vis-
its at our medical outpatient unit. Second, if no hypertensive 
crisis was recorded, a structured patient interview by phone 
was conducted. Third, additional information was obtained 
from the general practitioner using a structured interview, if 
the structured patient interview did not provide clear enough 
information on whether a hypertensive crisis had occurred or 
not. If a patient experienced more than one hypertensive crisis, 
only the first event was assessed.
Statistical methods. Data were analyzed using Stata software 
(Stata 11.0; StataCorp LP, College Station, TX). Student’s t-test 
was used for continuous variables after checking for normal 
distribution. Mann–Whitney rank-sum test was used for non-
normally distributed continuous variables. χ2-analysis was 
used for categorical variables with cell counts ≥5; if cell counts 
were <5, Fisher’s exact test was used. Cox proportional haz-
ards models were used to compare hypertensive crisis event 
rates between different risk factor categories. Hazard ratios 
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and 95% confidence intervals are provided. Cox proportional 
hazards models were performed for bivariable relationships 
as well as after adjustment for age and sex. Logistic regression 
models were used to detect associations between independent 
 variables and dichotomous, time-independent outcomes.
results
Follow-up was complete in 85 (95.5%) of the 89 participating 
patients (Figure 1). Four patients (4.5%) were lost to follow-up 
and excluded from the analysis. In none of these patients was 
hypertensive crisis or death believed to be the cause for the 
loss (two patients moved away and did not communicate their 
new address; two patients were either asylum seekers or for-
eign workers and left the country during follow-up). The mean 
duration of follow-up was 1.6 ± 0.3 years (range 1.0–2.4 years).
Baseline characteristics are summarized in Table 1. The 
mean age was 53.8 ± 14.9 years (range 19.9–82.6 years). A 
rather high proportion of patients were obese with a BMI 
≥30.0 kg/m2. Sixty-nine patients (81.2%) had a prescription for 
one or more antihypertensive drugs. Sixteen patients (18.8%) 
were primarily treated by lifestyle intervention and received 
no antihypertensive drugs. The mean number of prescribed 
antihypertensive drugs was 2.0 ± 1.6 (range 0–6). Sixty-seven 
patients (78.8%) had an automated BP device for home BP 
measurement.
Thirteen patients (15.3%) experienced a hypertensive crisis 
during follow-up. The mean duration between study inclu-
sion and hypertensive crisis was 303 ± 190 days (range 43–613 
days). At the time of hypertensive crisis, mean systolic BP was 
212 ± 22 mm Hg and mean diastolic BP was 118 ± 14 mm Hg. 
Eleven patients (84.6%) had symptoms during hypertensive 
crisis (e.g., headache, dizziness, visual impairment, nausea). 
During the structured patient interview, six patients reported 
a specific cause for the hypertensive crisis: three patients were 
nonadherent to the prescribed antihypertensive drug  therapy, 
two patients reported emotional stress, and one patient 
 suffered from symptomatic hyperthyroidism at the time of 
 hypertensive crisis.
Several baseline characteristics significantly differed in 
patients who experienced a hypertensive crisis and those who 
did not (Table 1). Patients with hypertensive crisis were older, 
more often were women, had a higher prevalence of hyperten-
sive heart disease or coronary artery disease, and more often 
had a previous stroke, a thyroid disease, or a somatoform dis-
order. The number of prescribed antihypertensive drugs was 
higher among patients with hypertensive crisis. Nonadherence 
to medication was more prevalent in patients who experi-
enced a hypertensive crisis: 10 of the 13 patients (76.9%) who 
experienced a hypertensive crisis had a remark in the medical 
record that the patient was nonadherent. None of the measures 
derived from 24-h ABPM was significantly different between 
patients with and without hypertensive crisis.
To detect associations of potential risk factors with hyper-
tensive crisis, Cox proportional hazards models were per-
formed. Several factors were significantly associated with 
hypertensive crisis in bivariable analysis as well as after adjust-
ment for age and sex (Table 2): female sex, higher grades of 
obesity, the presence of a hypertensive heart disease or a coro-
nary artery disease, the presence of a somatoform disorder, a 
higher number of antihypertensive drugs, and nonadherence 
to medication. As measured by the hazard ratio, nonadherence 
was the most important factor associated with hypertensive 
crisis. Figure 2 shows the occurrence of hypertensive crisis 
subdivided by patients with nonadherence and patients with 
adherence to medication.
The presence of a somatoform disorder (P < 0.01) and a 
higher number of antihypertensive drugs (P = 0.04) were sig-
nificantly associated with nonadherence to medication. The 
association remained significant, if the regression model was 
adjusted by age and sex.
None of the 16 patients who were treated by lifestyle inter-
vention and who did not receive antihypertensive drugs expe-
rienced a hypertensive crisis. Therefore, a sensitivity analysis 
without these 16 patients was performed. In Cox proportional 
hazards models adjusted for age and sex, the following factors 
were significantly associated with the occurrence of a hyper-
tensive crisis: female sex (P < 0.01), higher grades of obesity 
(P = 0.01), the presence of a somatoform disorder (P < 0.01), 
Figure 1 | Flow chart.
112 Eligible patients:
- Aged 18 years or older, and
- Ambulatory blood pressure measurement performed
Excluded:
- 21 Normotensive patients
- 2 Patients refused participation
89 Participating patients
85 Patients completed study and
were included in analysis
Lost to follow-up:
- 4 Patients
Figure 2 | Kaplan–Meier failure estimates for the occurrence of hypertensive 
crisis subdivided for patients with nonadherence or adherence to medication.
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a higher number of antihypertensive drugs (P = 0.04), and 
 nonadherence to medication (P = 0.02). The presence of a 
hypertensive heart disease (P = 0.05) or a coronary artery dis-
ease (P = 0.06) were close to significance. Thus, these results 
were similar to the results presented in Table 2.
discussion
This prospective longitudinal study identified several poten-
tial risk factors for hypertensive crisis, namely female sex, the 
grade of obesity, the presence of a hypertensive heart disease 
or a coronary artery disease, the presence of a somatoform dis-
order, a higher number of prescribed antihypertensive drugs, 
and, most importantly, nonadherence to medication. However, 
confounding or interaction between these potential risk factors 
cannot be excluded due to the small sample size. For example, 
the presence of a somatoform disorder and a higher number 
of prescribed antihypertensive drugs were significantly associ-
ated with nonadherence suggesting a relation between these 
three factors. This study also suggests that there are specific 
causes for hypertensive crisis such as hyperthyroidism in some 
patients.
Previous retrospective studies have presumed that nonad-
herence to medication is an important risk factor for hyper-
tensive crisis.3–8 Our results now support this previous finding 
in a first prospective longitudinal study. This study therefore 
contributes to the ongoing discussion about whether non-
adherence is an explanation for hypertensive crisis or not.9 
Nonadherence was significantly associated with a higher 
table 1 | Baseline characteristics (mean ± s.d. or percentage)
Characteristic
Patients without 
hypertensive crisis
Patients with 
hypertensive crisis
P value
All patients
(N = 72) (N = 13) (N = 85)
Age, years 52.3 ± 15.2 61.8 ± 10.1 0.03 53.8 ± 14.9
Female sex, n (%) 23 (31.9) 10 (76.9) <0.01 33 (38.8)
Systolic BP, mm Hg 137.3 ± 13.0 142.1 ± 16.7 0.24 138.0 ± 13.6
Diastolic BP, mm Hg 80.5 ± 10.9 78.2 ± 11.4 0.49 80.1 ± 10.9
Hypertension, n (%) 72 (100.0) 13 (100.0) 1 85 (100.0)
 Stage 1, n (%) 53 (73.6) 7 (53.9) 0.15 60 (70.6)
 Stage 2, n (%) 19 (26.4) 6 (46.1) 25 (29.4)
Body mass index, kg/m2 29.3 ± 6.3 32.3 ± 6.0 0.11 29.8 ± 6.3
Obesity, n (%) 30 (41.7) 8 (61.5) 0.19 38 (44.7)
 Grade 0, n (%) 42 (58.3) 5 (38.5) 0.04 47 (55.3)
 Grade 1, n (%) 20 (27.8) 2 (15.4) 22 (25.9)
 Grade 2, n (%) 6 (8.3) 5 (38.5) 11 (12.9)
 Grade 3, n (%) 4 (5.6) 1 (7.7) 5 (5.9)
Hyperlipidemia, n (%) 41 (56.9) 10 (76.9) 0.23 51 (60.0)
Diabetes, n (%) 14 (19.4) 4 (30.8) 0.46 18 (21.2)
Nicotine, n (%) 35 (48.6) 5 (38.5) 0.5 40 (47.1)
Hypertensive heart disease, n (%) 15 (20.8) 7 (53.9) 0.01 22 (25.9)
Coronary artery disease, n (%) 5 (6.9) 4 (30.8) 0.03 9 (10.6)
Hypertensive renal disease, n (%) 8 (11.1) 2 (15.4) 0.65 10 (11.8)
Creatinine, μmol/l 75.6 ± 13.2 79.1 ± 20.7 0.42 76.1 ± 14.5
Renal artery stenosis, n (%) 1 (1.4) 0 (0.0) 1 1 (1.2)
Previous stroke, n (%) 3 (4.2) 3 (23.1) 0.04 6 (7.1)
Thyroid disease, n (%) 10 (13.9) 5 (38.5) 0.03 15 (17.7)
Hyperthyroidism, n (%) 0 (0.0) 1 (7.7) 0.15 1 (1.2)
Depression, n (%) 13 (18.1) 5 (38.5) 0.1 18 (21.2)
Somatoform disorder, n (%) 5 (6.9) 4 (30.8) 0.03 9 (10.6)
Antihypertensive drugs, number of drugs 1.8 ± 1.5 3.0 ± 1.4 <0.01 2.0 ± 1.6
Nonadherence to medication, n (%) 16 (22.2) 10 (76.9) <0.01 26 (30.6)
Achieved BP control during ABPM, n (%) 38 (52.8) 7 (53.9) 0.94 45 (52.9)
Alcohol abuse, n (%) 12 (16.7) 2 (15.4) 1 14 (16.5)
ABPM, ambulatory blood pressure monitoring; BP, blood pressure.
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number of prescribed antihypertensive drugs. This is a 
well-known phenomenon.18 Therefore, this study suggests that 
a higher number of prescribed antihypertensive drugs is not a 
true risk factor for hypertensive crisis, but related to hyperten-
sive crisis via nonadherence.
In this study, the proportion of women experiencing hyper-
tensive crisis was higher than that of men. Several previous 
studies found indications of an increased incidence of hyper-
tensive crisis in women, but without satisfying explanations 
for these findings.4,19,20 It is well established that women more 
often suffer from somatoform disorders as compared to men 
and that this disease is associated with nonadherence.21–23 
Therefore, a plausible explanation for the findings of our study 
might be that women had a higher prevalence of somato-
form disorders predisposing these women to nonadherence. 
Regression analysis in our study supports this hypothesis.
A further finding was that the risk for hypertensive crisis was 
associated with the grade of obesity at the time of diagnosis. 
To the best of the authors’ knowledge, this finding has previ-
ously not been reported. However, it is known that hyperten-
sion control is more difficult in obese than in lean patients. The 
underlying pathophysiological mechanism is not fully under-
stood, but overactivity of the sympathetic nervous system (e.g., 
due to hyperleptinemia) or the renin–angiotensin–aldosterone 
system as well as physical compression of the kidneys seem to 
play a role in this scenario.24,25
Our study has limitations. First, the sample size of 85 patients 
was small. It was too small for meaningful multivariable regres-
sion models involving more than three variables. However, 
sample size was adequate to identify several significant asso-
ciations as potential risk factors of hypertensive crises. Second, 
the patients included in this study had 24-h ABPM at a uni-
versity hospital which might have led to a selection of patients 
with rather severe hypertension, thus possibly limiting the 
generalizability of our data. Third, some hypertensive crises 
may have been missed because it was impossible to continually 
monitor BP during follow-up. Furthermore, unequal follow-up 
periods or patients lost to follow-up may have led to missed 
hypertensive crises. However, outpatient medical records were 
reviewed in all and structured interviews were conducted 
with most study participants. The approach in this study has 
been proven to be effective in the detection of end points.26,27 
Fourth, to be plausible, the association between medical non-
adherence and hypertensive crisis requires a proper definition 
of nonadherence. Generally, medical adherence is defined as 
the extent to which a patient takes a medication as prescribed 
by the treating physician.28 Patients were considered as being 
nonadherent, if the treating physician asked the patient 
whether he took medication irregularly and if irregular media-
tion use was documented in the medical record. This approach 
should be appropriate. Methods such as pharmacy refills or 
electronic monitoring of pill cap openings have been shown to 
be insensitive methods for measuring medical adherence and 
are not superior to physician’s judgment.29
This study has research implications. Several potential risk 
factors for hypertensive crisis were identified, among them 
nonadherence to medication. These findings have to be con-
firmed in a larger independent prospective study extended 
to a more generalized study population (i.e., a study popula-
tion also seen by general practitioners). Ideally, such a study 
should not only incorporate the risk factors assessed in this 
study, but also extend the baseline assessment by further 
potential explanatory variables (e.g., measurements of differ-
ent  hormones, including leptin and insulin levels to explore 
the association between obesity and hypertensive crisis). 
Such a future study might also assess genetic polymorphisms 
table 2 | Variables associated with hypertensive crisis
Variable
Bivariable analysis Multivariable analysisa
HR (95% CI) P value HR (95% CI) P value
Age (HR per year increase) 1.04 (1.00–1.08) 0.05 1.03 (0.99–1.07) 0.14
Sex (HR for female vs. male sex) 6.15 (1.69–22.37) <0.01 5.27 (1.43–19.47) 0.01
Stage of hypertension (HR for stage 2 vs. stage 1) 2.17 (0.73–6.47) 0.16 2.48 (0.81–7.57) 0.11
Grade of obesity (HR per grade increase) 1.68 (1.01–2.79) 0.046 2.28 (1.19–4.37) 0.01
Hypertensive heart disease (HR for presence vs. absence) 3.82 (1.28–11.40) 0.02 4.14 (1.16–14.81) 0.03
Coronary artery disease (HR for presence vs. absence) 4.43 (1.36–14.44) 0.01 3.73 (1.09–12.80) 0.04
Previous stroke (HR for presence vs. absence) 4.39 (1.21–15.97) 0.03 3.02 (0.72–12.72) 0.13
Thyroid disease (HR for presence vs. absence) 3.09 (1.01–9.48) 0.048 1.74 (0.52–5.82) 0.37
Depression (HR for presence vs. absence) 2.36 (0.77–7.21) 0.13 2.13 (0.65–6.98) 0.21
Somatoform disorder (HR for presence vs. absence) 4.55 (1.39–14.87) 0.01 5.05 (1.34–19.03) 0.02
Number of antihypertensive drugs  
(HR per number of drug increase)
1.45 (1.07–1.97) 0.02 1.68 (1.16–2.44) <0.01
Nonadherence to medication  
(HR for nonadherence vs. adherence)
8.51 (2.34–30.95) <0.01 5.88 (1.59–21.77) <0.01
CI, confidence interval; HR, hazard ratio.
aAdjustment for age and sex.
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 associated with hypertensive crisis, increased susceptibility 
to side effects and medication interactions, and/or vascular 
 properties (such as the measurement of pulse wave velocity or 
augmentation index).30–32
In conclusion, this study identified several risk factors for 
hypertensive crisis, among them nonadherence to medica-
tion. Even though there are open questions, this study suggests 
that the improvement of medical adherence in antihyperten-
sive drug therapy is important to prevent hypertensive crises. 
Physicians should be aware of medical nonadherence in some 
subpopulations such as patients with somatoform disorders.
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